October 2013 - This Month in JoVE
October 3rd, 2013
2.1K views
Here's a look at what's coming up in the October 2013 issue of JoVE.
Overview
The October 2013 issue of JoVE introduces the new JoVE Environment section, highlighting innovative research methods in environmental sciences and green technologies. Featured articles cover minimally invasive tree endotherapy, optimized genetic crossing in Setaria viridis, advanced microvascular chip assays, and high-resolution brain imaging techniques. These methods aim to advance sustainability, genetic research, microvascular modeling, and neuroanatomical studies.
Key Study Components
Area of Science
- Environmental Science
- Plant Biology
- Bioengineering
- Neuroscience
Background
- Traditional tree endotherapy often damages trees due to drilling.
- Genetic crosses in Setaria viridis are important for bioenergy and crop research.
- Microvascular systems-on-a-chip are essential for in vitro vascular studies.
- High-resolution imaging of brain tissue is critical for neuroanatomical research.
Purpose of Study
- To introduce minimally invasive methods for tree endotherapy.
- To optimize genetic crossing techniques in Setaria viridis.
- To develop advanced microfluidic assays for vascular research.
- To present non-destructive, high-resolution brain imaging methods.
Methods Used
- Drill-free tree endotherapy using a perforated blade and Venturi effect.
- Heat-based emasculation for genetic crosses in Setaria viridis with GUS transgene identification.
- Fabrication of endothelialized microchannels-on-a-chip using photolithography and soft lithography.
- Confocal light sheet microscopy (CLSM) for optical tomography of mouse brains.
Main Results
- Minimally invasive endotherapy increases uptake of compounds in trees while reducing damage.
- Heat-based emasculation accelerates genetic discovery in Setaria viridis.
- Microvascular chips enable controlled, long-term perfusion and accurate flow over endothelial cells.
- CLSM provides micron-scale, three-dimensional images of whole mouse brains without physical sectioning.
Conclusions
- Innovative methods in JoVE Environment advance sustainable and minimally invasive research.
- Optimized genetic and microfluidic techniques support rapid discovery and modeling.
- Advanced imaging technologies enhance anatomical studies without destructive procedures.
Frequently Asked Questions
What is tree endotherapy and how is it improved in this issue?
Tree endotherapy is a method for delivering compounds directly into trees. The featured drill-free technique uses a perforated blade and the Venturi effect to minimize tree damage and enhance uptake.
How does the new genetic crossing method in Setaria viridis work?
Instead of manual anther removal, heat is used to kill pollen grains, and a GUS transgene helps identify successful crosses, streamlining genetic research.
What advancements are made in microvascular research?
A microfluidic chip with endothelialized channels mimics in vivo microvessels, allowing precise, long-term perfusion studies of cultured endothelial cells.
What is confocal light sheet microscopy (CLSM) and its benefit?
CLSM is an optical imaging technique that produces high-resolution, three-dimensional images of whole mouse brains without the need for physical sectioning.
What is the focus of the new JoVE Environment section?
JoVE Environment focuses on multidisciplinary research methods in environmental sciences and green technologies, aiming to promote sustainability and resource protection.
How do these methods contribute to sustainability?
By reducing invasiveness in tree treatments, optimizing crop genetics, and improving research models, these methods support more sustainable and efficient scientific practices.
Executive Industry Relevance
The October 2013 JoVE issue highlights enabling technologies for minimally invasive compound delivery, genetic model optimization, microvascular assay development, and high-resolution tissue imaging. These advances support predictive confidence and mechanistic de-risking at critical inflection points in biopharma discovery and translational research. The featured methods enhance workflow integration, reproducibility, and scalability across early discovery and preclinical pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Facilitates minimally invasive compound delivery for functional studies in plant models.
- Enables rapid genetic manipulation and trait validation in emerging crop systems.
- Supports mechanistic de-risking through advanced imaging and model fidelity.
Screening & Assay Development
- Prepares validated biological systems for downstream compound screening workflows.
- Delivers standardized, reproducible microvascular assays for quantitative evaluation.
- Enables scalable, platform-ready models for high-throughput screening and analysis.
Translational & Preclinical Research
- Aligns model systems with disease-relevant and translational biomarker studies.
- Provides continuity from discovery through preclinical validation using advanced imaging.
- Reduces risk in advancing candidates by improving predictive model accuracy.
Pipeline & Workflow Integration
These methods position within the discovery continuum from early hypothesis testing and target validation to assay development and preclinical model optimization.
- Discovery Biology: Supports hypothesis-driven compound delivery and genetic manipulation in model systems.
- Screening: Provides reproducible, quantitative microvascular assays for compound evaluation.
- Analytics: Enables high-resolution, three-dimensional imaging for comparative tissue analysis.
- Translational Research: Bridges discovery and preclinical research with scalable, disease-relevant models.
- Enterprise Reuse: Establishes reusable platforms for ongoing R&D and cross-project standardization.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in early research.
- Operational Value: Enhances standardization, reproducibility, and scalability of experimental workflows.
- Strategic Value: Improves go/no-go decision-making and capital efficiency across the portfolio.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of discovery and preclinical assets.
Implementation Considerations
- Requires expertise in plant physiology, microfluidics, or advanced imaging as relevant.
- Demands access to specialized instrumentation for microchannel fabrication and optical tomography.
- Benefits from cross-team standardization for reproducibility and data comparability.
- May require adaptation for different model systems or compound classes.
- Minimally invasive methods reduce operational risk but may have system-specific limitations.
Biopharma FAQs
Why does null hypothesis testing matter for tree endotherapy validation?
Null hypothesis testing in minimally invasive tree endotherapy enables objective assessment of compound uptake and delivery efficiency, supporting robust target validation and reducing mechanistic uncertainty in early discovery workflows.
How does independent variable isolation fit microvascular chip assay development?
Isolating flow rate and channel geometry variables in endothelialized microchannels-on-a-chip allows precise evaluation of vascular responses, enhancing assay development and supporting reliable screening of candidate compounds.
What do quantitative dependent variable measurements enable in Setaria genetic crosses?
Quantitative measurement of GUS transgene expression in Setaria crosses enables accurate identification of successful genetic events, streamlining trait validation and accelerating model optimization for downstream R&D.
Why are replication requirements critical for confocal light sheet microscopy studies?
Replication in confocal light sheet microscopy ensures reproducibility of high-resolution brain imaging, facilitating cross-functional collaboration and reliable anatomical comparisons across research teams.
What statistical analysis capabilities are required before implementing these advanced methods?
Robust statistical analysis is essential to validate experimental outputs, compare conditions, and support data-driven decisions before integrating these minimally invasive, quantitative, and imaging-based methods into biopharma pipelines.